Literature DB >> 22143420

Tumor size and depth predict rate of lymph node metastasis in colon carcinoids and can be used to select patients for endoscopic resection.

Riad H Al Natour1, Mandeep S Saund, Vivian M Sanchez, Edward E Whang, Ashish M Sharma, Qin Huang, Valia A Boosalis, Jason S Gold.   

Abstract

BACKGROUND: Regional lymphadenectomy is recommended for all colon carcinoids, whereas resection without lymphadenectomy is accepted for selected appendiceal and rectal carcinoids. We examined the relation of tumor size and depth to lymph node metastasis in order to determine whether colon carcinoids could be selected for endoscopic resection.
METHODS: Patients were identified from the Surveillance Epidemiology and End Results Registry. The Pearson chi-square and the log rank tests were used. P < 0.05 was considered significant.
RESULTS: We identified 929 patients who underwent resection of localized colon carcinoids without distant metastasis diagnosed from 1973 to 2006. The diagnosis of small and superficial tumors increased over time (p < 0.001). The presence of lymph node metastasis was adversely associated with survival (p < 0.001); however, there was only a trend toward independence on multivariate analysis (p = 0.054). Tumor size and depth were associated with lymph node metastasis (p < 0.001, p < 0.001). Tumors were subgrouped by size and depth to find cases with a low risk of lymph node metastasis. Intramucosal tumors < 1 cm had a 4% rate of lymph node metastasis, while all other subgroups had rates ≥ 14%.
CONCLUSION: Tumor size and depth predict lymph node metastasis for colon carcinoids. Endoscopic resection may be appropriate for intramucosal tumors <1 cm.

Entities:  

Mesh:

Year:  2011        PMID: 22143420     DOI: 10.1007/s11605-011-1786-1

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  15 in total

Review 1.  Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

Authors:  U Plöckinger; G Rindi; R Arnold; B Eriksson; E P Krenning; W W de Herder; A Goede; M Caplin; K Oberg; J C Reubi; O Nilsson; G Delle Fave; P Ruszniewski; H Ahlman; B Wiedenmann
Journal:  Neuroendocrinology       Date:  2005-04-18       Impact factor: 4.914

2.  Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours.

Authors:  J K Ramage; A H G Davies; J Ardill; N Bax; M Caplin; A Grossman; R Hawkins; A M McNicol; N Reed; R Sutton; R Thakker; S Aylwin; D Breen; K Britton; K Buchanan; P Corrie; A Gillams; V Lewington; D McCance; K Meeran; A Watkinson
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

3.  Carcinoid tumors of the colon. A study of 72 patients.

Authors:  J M Rosenberg; J P Welch
Journal:  Am J Surg       Date:  1985-06       Impact factor: 2.565

4.  Incidence and mortality of carcinoids of the colon. Data from the Connecticut Tumor Registry.

Authors:  G H Ballantyne; P E Savoca; J T Flannery; M H Ahlman; I M Modlin
Journal:  Cancer       Date:  1992-05-15       Impact factor: 6.860

5.  Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971.

Authors:  Libby Ellis; Matthew J Shale; Michel P Coleman
Journal:  Am J Gastroenterol       Date:  2010-09-07       Impact factor: 10.864

6.  Colon carcinoid tumors. A population-based study.

Authors:  C Spread; H Berkel; L Jewell; H Jenkins; W Yakimets
Journal:  Dis Colon Rectum       Date:  1994-05       Impact factor: 4.585

Review 7.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

Review 8.  Carcinoid tumors.

Authors:  Scott N Pinchot; Kyle Holen; Rebecca S Sippel; Herbert Chen
Journal:  Oncologist       Date:  2008-12-17

9.  A 5-decade analysis of 13,715 carcinoid tumors.

Authors:  Irvin M Modlin; Kevin D Lye; Mark Kidd
Journal:  Cancer       Date:  2003-02-15       Impact factor: 6.860

10.  Neuroendocrine carcinomas of the colon and rectum.

Authors:  P E Bernick; D S Klimstra; J Shia; B Minsky; L Saltz; W Shi; H Thaler; J Guillem; P Paty; A M Cohen; W D Wong
Journal:  Dis Colon Rectum       Date:  2004-02       Impact factor: 4.585

View more
  22 in total

1.  Unfavorable effect of small tumor size on cause-specific survival in stage IIA colon cancer, a SEER-based study.

Authors:  Yuwei Wang; Changhua Zhuo; Debing Shi; Hongtu Zheng; Ye Xu; Weilie Gu; Sanjun Cai; Guoxiang Cai
Journal:  Int J Colorectal Dis       Date:  2014-11-13       Impact factor: 2.571

2.  The Critical Role of Tumor Size in Predicting Prognosis for T1 Colon Cancer.

Authors:  Weixing Dai; Shaobo Mo; Wenqiang Xiang; Lingyu Han; Qingguo Li; Renjie Wang; Ye Xu; Guoxiang Cai
Journal:  Oncologist       Date:  2019-11-20

3.  A comparison of endoscopic treatments in rectal carcinoid tumors.

Authors:  Hyun Joo Lee; Seong Beom Kim; Cheol Min Shin; A Young Seo; Dong Ho Lee; Nayoung Kim; Young Soo Park; Hyuk Yoon
Journal:  Surg Endosc       Date:  2015-10-30       Impact factor: 4.584

4.  The Critical Role of Tumor Size in Predicting Prognosis for T1 Colon Cancer.

Authors:  Weixing Dai; Shaobo Mo; Wenqiang Xiang; Lingyu Han; Qingguo Li; Renjie Wang; Ye Xu; Guoxiang Cai
Journal:  Oncologist       Date:  2019-11-20

5.  Clinicopathologic characteristics of colonic carcinoid tumors.

Authors:  Sara E Murray; Ricardo V Lloyd; Rebecca S Sippel; Herbert Chen
Journal:  J Surg Res       Date:  2013-06-21       Impact factor: 2.192

6.  Nomogram predicting the risk of recurrence after curative-intent resection of primary non-metastatic gastrointestinal neuroendocrine tumors: An analysis of the U.S. Neuroendocrine Tumor Study Group.

Authors:  Katiuscha Merath; Fabio Bagante; Eliza W Beal; Alexandra G Lopez-Aguiar; George Poultsides; Eleftherios Makris; Flavio Rocha; Zaheer Kanji; Sharon Weber; Alexander Fisher; Ryan Fields; Bradley A Krasnick; Kamran Idrees; Paula M Smith; Cliff Cho; Megan Beems; Carl R Schmidt; Mary Dillhoff; Shishir K Maithel; Timothy M Pawlik
Journal:  J Surg Oncol       Date:  2018-02-15       Impact factor: 3.454

7.  Prognosis of incompletely resected small rectal neuroendocrine tumor using endoscope without additional treatment.

Authors:  Boram Cha; Jongbeom Shin; Weon Jin Ko; Kye Sook Kwon; Hyungkil Kim
Journal:  BMC Gastroenterol       Date:  2022-06-09       Impact factor: 2.847

8.  Outcomes for a Large Cohort of Patients with Rectal Neuroendocrine Tumors: an Analysis of the National Cancer Database.

Authors:  Beiqun Zhao; Hannah M Hollandsworth; Nicole E Lopez; Lisa A Parry; Benjamin Abbadessa; Bard C Cosman; Sonia L Ramamoorthy; Samuel Eisenstein
Journal:  J Gastrointest Surg       Date:  2020-02-03       Impact factor: 3.452

9.  Endoscopic submucosal resection with an endoscopic variceal ligation device for the treatment of rectal neuroendocrine tumors.

Authors:  Masahide Ebi; Shoko Nakagawa; Yoshiharu Yamaguchi; Yasuhiro Tamura; Shinya Izawa; Yasutaka Hijikata; Takaya Shimura; Yasushi Funaki; Naotaka Ogasawara; Makoto Sasaki; Takashi Joh; Kunio Kasugai
Journal:  Int J Colorectal Dis       Date:  2018-08-30       Impact factor: 2.571

10.  Factors associated with worse outcomes for colorectal neuroendocrine tumors in radical versus local resections.

Authors:  Osayande Osagiede; Elizabeth Habermann; Courtney Day; Emmanuel Gabriel; Amit Merchea; Riccardo Lemini; Iktej S Jabbal; Dorin T Colibaseanu
Journal:  J Gastrointest Oncol       Date:  2020-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.